• Gene deletion; HGNC; HGNC:1787; CDKN2A; Zygosity=Homozygous; Note=Possible (Direct_author_submission).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; c.704_735del32; Zygosity=Unspecified (PubMed=25184754).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg306Ter (c.916C>T); ClinVar=VCV000142144; Zygosity=Unspecified (PubMed=25184754).
  

PubMed=12175565; DOI=10.1016/S0167-8140(01)00498-4
Begg A.C., Sprong D., Balm A.J.M., Coco-Martin J.M.
Premature chromosome condensation and cell separation studies in biopsies from head and neck tumors for radiosensitivity prediction.
Radiother. Oncol. 62:335-343(2002)

PubMed=25184754; DOI=10.1371/journal.pone.0106301; PMCID=PMC4153646
Aydin S., Dekairelle A.-F., Ambroise J., Durant J.-F., Heusterspreute M., Guiot Y., Cosyns J.-P., Gala J.-L.
Unambiguous detection of multiple TP53 gene mutations in AAN-associated urothelial cancer in Belgium using laser capture microdissection.
PLoS ONE 9:E106301-E106301(2014)

PubMed=26032726; DOI=10.1186/s13104-015-1197-6; PMCID=PMC4467624
Boeckx C., Van den Bossche J., De Pauw I., Peeters M., Lardon F., Baay M., Wouters A.
The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines.
BMC Res. Notes 8:203.1-203.6(2015)

PubMed=26269754; PMCID=PMC4529614
Boeckx C., Blockx L., Op de Beeck K., Limame R., Van Camp G., Peeters M., Vermorken J.B., Specenier P., Wouters A., Baay M., Lardon F.
Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor.
Am. J. Cancer Res. 5:1921-1938(2015)